9-130854047-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005157.6(ABL1):c.80-17C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ABL1
NM_005157.6 intron
NM_005157.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.109
Publications
0 publications found
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
- congenital heart defects and skeletal malformations syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- connective tissue disorderInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- bone development diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABL1 | ENST00000318560.6 | c.80-17C>T | intron_variant | Intron 1 of 10 | 1 | NM_005157.6 | ENSP00000323315.5 | |||
ABL1 | ENST00000372348.9 | c.137-17C>T | intron_variant | Intron 1 of 10 | 1 | ENSP00000361423.2 | ||||
ABL1 | ENST00000393293.4 | c.137-20C>T | intron_variant | Intron 1 of 1 | 5 | ENSP00000376971.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1419828Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 703084
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1419828
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
703084
African (AFR)
AF:
AC:
0
AN:
31286
American (AMR)
AF:
AC:
0
AN:
34840
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24154
East Asian (EAS)
AF:
AC:
0
AN:
39152
South Asian (SAS)
AF:
AC:
0
AN:
80264
European-Finnish (FIN)
AF:
AC:
0
AN:
52750
Middle Eastern (MID)
AF:
AC:
0
AN:
5574
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1093312
Other (OTH)
AF:
AC:
0
AN:
58496
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.